NGC Update Service: July 4, 2016 || National Institute for Health and Care Excellence (NICE)

NGC Update Service: July 4, 2016

National Institute for Health and Care Excellence (NICE)

• Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia. This updates a previously published guideline summary.
• TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis. This updates a previously published guideline summary.